Literature DB >> 34115535

Transthoracic Echocardiography: Beginner's Guide with Emphasis on Blind Spots as Identified with CT and MRI.

Matthew D Grant1, Ryan D Mann1, Scott D Kristenson1, Richard M Buck1, Juan D Mendoza1, Jason M Reese1, David W Grant1, Eric A Roberge1.   

Abstract

Transthoracic echocardiography (TTE) is the primary initial imaging modality in cardiac imaging. Advantages include portability, safety, availability, and ability to assess the morphology and physiology of the heart in a noninvasive manner. Because of this, many patients who undergo advanced imaging with CT or MRI will have undergone prior TTE, particularly when cardiac CT angiography or cardiac MRI is performed. In the modern era, the increasing interconnectivity of picture archiving and communication systems (PACS) has made these images more available for comparison. Therefore, radiologists who interpret chest imaging studies should have a basic understanding of TTE, including its strengths and limitations, to make accurate comparisons and assist in rendering a diagnosis or avoiding a misdiagnosis. The authors present the standard TTE views along with multiplanar reformatted CT images for correlation. This is followed by examples of limitations of TTE, focusing on potential blind spots, which have been placed in seven categories on the basis of the structures involved: (a) pericardium (thickening, calcification, effusions, cysts, masses), (b) aorta (dissection, intramural hematoma, penetrating atherosclerotic ulcer), (c) left ventricular apex (infarcts, aneurysms, thrombus, apical hypertrophic cardiomyopathy), (d) cardiac valves (complications of native and prosthetic valves), (e) left atrial appendage (thrombus), (f) coronary arteries (origins, calcifications, fistulas, aneurysms), and (g) extracardiac structures (primary and metastatic masses). Online supplemental material and the slide presentation from the RSNA Annual Meeting are available for this article . ©RSNA, 2021.

Entities:  

Mesh:

Year:  2021        PMID: 34115535      PMCID: PMC8493765          DOI: 10.1148/rg.2021200142

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   6.312


  61 in total

1.  Long-term outcome in patients with apical hypertrophic cardiomyopathy.

Authors:  Maria J Eriksson; Brian Sonnenberg; Anna Woo; Paul Rakowski; Thomas G Parker; E Douglas Wigle; Harry Rakowski
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

2.  Pathogenesis in acute aortic syndromes: aortic dissection, intramural hematoma, and penetrating atherosclerotic aortic ulcer.

Authors:  Katarzyna J Macura; Frank M Corl; Elliot K Fishman; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2003-08       Impact factor: 3.959

3.  Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring.

Authors:  Joshua D Mitchell; Nicole Fergestrom; Brian F Gage; Robert Paisley; Patrick Moon; Eric Novak; Michael Cheezum; Leslee J Shaw; Todd C Villines
Journal:  J Am Coll Cardiol       Date:  2018-12-25       Impact factor: 24.094

4.  Major congenital coronary artery anomalies in a paediatric and adult population: a prospective echocardiographic study.

Authors:  Fabien Labombarda; Guillaume Coutance; Arnaud Pellissier; Claire Mery-Alexandre; Vincent Roule; Pascale Maragnes; Paul Milliez; Eric Saloux
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-01-23       Impact factor: 6.875

5.  The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease.

Authors:  P G Hagan; C A Nienaber; E M Isselbacher; D Bruckman; D J Karavite; P L Russman; A Evangelista; R Fattori; T Suzuki; J K Oh; A G Moore; J F Malouf; L A Pape; C Gaca; U Sechtem; S Lenferink; H J Deutsch; H Diedrichs; J Marcos y Robles; A Llovet; D Gilon; S K Das; W F Armstrong; G M Deeb; K A Eagle
Journal:  JAMA       Date:  2000-02-16       Impact factor: 56.272

6.  Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.

Authors:  Raj R Makkar; Gregory Fontana; Hasan Jilaihawi; Tarun Chakravarty; Klaus F Kofoed; Ole De Backer; Federico M Asch; Carlos E Ruiz; Niels T Olsen; Alfredo Trento; John Friedman; Daniel Berman; Wen Cheng; Mohammad Kashif; Vladimir Jelnin; Chad A Kliger; Hongfei Guo; Augusto D Pichard; Neil J Weissman; Samir Kapadia; Eric Manasse; Deepak L Bhatt; Martin B Leon; Lars Søndergaard
Journal:  N Engl J Med       Date:  2015-10-05       Impact factor: 91.245

7.  Illustrative cases in pericardial effusion misdetection: correlation of echocardiography and CT.

Authors:  D Yousem; T T Traill; P S Wheeler; E K Fishman
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

8.  Echocardiographic manifestation of esophagitis mimicking a posterior mediastinal mass.

Authors:  Supreeya Swarup; Sowmya Kantamneni; Sarah Kabir; Roman Zeltser; Amgad N Makaryus
Journal:  Clin Med Insights Cardiol       Date:  2015-02-23

9.  Update on Cardiovascular Echo in Aortic Aneurysm and Dissection.

Authors:  Kazuhiro Nishigami
Journal:  Ann Vasc Dis       Date:  2018-12-25

10.  The usefulness of cardiac CT in the diagnosis of perivalvular complications in patients with infective endocarditis.

Authors:  Tomasz Hryniewiecki; Karina Zatorska; Elżbieta Abramczuk; Dariusz Zakrzewski; Piotr Szymański; Mariusz Kuśmierczyk; Ilona Michałowska
Journal:  Eur Radiol       Date:  2019-01-14       Impact factor: 5.315

View more
  2 in total

1.  Imaging of left heart intracardiac thrombus: clinical needs, current imaging, and emerging cardiac magnetic resonance techniques.

Authors:  Peng Chang; Jiayu Xiao; Zhehao Hu; Alan C Kwan; Zhaoyang Fan
Journal:  Ther Adv Cardiovasc Dis       Date:  2022 Jan-Dec

Review 2.  Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review.

Authors:  Miroslawa Gorecka; Malenka M Bissell; David M Higgins; Pankaj Garg; Sven Plein; John P Greenwood
Journal:  J Cardiovasc Magn Reson       Date:  2022-08-22       Impact factor: 6.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.